Rare Kidney Stone Consortium Funds 5-year Renewal of Studies

David Goldfarb, MD and Lada Beara-Lasic, MD to lead two of four funded research studies

The Nephrology Division is pleased to announce a 5 year renewal of the Rare Kidney Stone Consortium (RKSC), part of the Rare Diseases Clinical Research Network, funded by the National Institute of Diabetes, Digestive and Kidney Diseases, and the National Center for Advancing Translation Sciences (NCATS). The RKSC studies 4 genetic causes of kidney stones including primary hyperoxaluria, cystinuria, Dent disease and adenine phosphoribosyltransferase deficiency.


Dr. David Goldfarb, Clinical Chief of Nephrology at NYU Langone Medical Center and Professor of Medicine and Physiology at NYU School of Medicine is the PI of the Cystinuria project. Dr. Lada Beara-Lasic, Assistant Professor of Medicine at NYU SoM is a co-investigator of the Dent disease project.

Related links: